India’s troubled hospital group Fortis Health has selected IHH Healthcare to take control of the company ahead of an alternative bid by rival TPG-Manipal.
The fight for Fortis, India's second largest and arguably most troubled hospital group, could soon be over. Healthcare Nova hears from a well-placed India-based source that IHH Healthcare's binding offer to acquire 51% of the company is extremely likely to succeed.
Malaysia-based outpatient and corporate care group Qualitas has further delayed its listing on the Singapore Exchange (SGX), after lowering the value of its IPO, a market source tells Healthcare Nova.
Taiwanese outpatient clinic group Ma Kuang, which mixes 'Western' medicine with traditional Chinese medicine (TCM), talks candidly with Healthcare Nova about the challenges of operating in China - and why its future is digital.
The Asian healthcare market is desperately in need of good providers but the operating environment remains challenging, according to the panel of experts at HBI 2018.
Malaysian hospital group IHH Healthcare has re-launched its takeover offer for Indian hospital operator Fortis. But it's not the only bidder in a web of rumoured takeovers involving buyers with deep pockets from both the Far East and West. We talk to local contacts.
Malaysia-based outpatient and corporate care group Qualitas’ planned IPO on the Singapore Exchange is “work in progress” and has been delayed to later this year, a well-placed source tells Healthcare Nova. HCN reported at the end of 2017 that Qualitas was planning to list on Singapore Exchange (SGX) to raise S$200m (US$152m) in early 2018. […]
Singapore-based property developer and Chinese health care service operator Perennial Real Estate Holdings reported soaring profits in 2017. We look at its strategy of building hospitals and care homes, often close to high-speed rail hubs. Perennial is pouring some of its profits as a real estate developer into building health care services in China. Perennial remained […]
Mark Middleton is group CEO of Icon, the Australian cancer care specialist which is making inroads into Singapore and China. He speaks to Healthcare Nova about the group's strategy to date, how it is expanding into South East Asia, and its plans for expansion.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
